Skip to main content
Clinical Trials/JPRN-UMIN000017047
JPRN-UMIN000017047
Completed
Phase 4

A randomized, open-label clinical trial on the efficacy of blonanserin and olanzapine in patients with schizophrenia and dopamine supersensitivity psychosis - Replacement with the Optimal Antipsychotic for Dopamine Supersensitivity Study (ROADS Study)

Chiba University Hospital Clinical Research Center0 sites61 target enrollmentApril 10, 2015

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Chiba University Hospital Clinical Research Center
Enrollment
61
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 10, 2015
End Date
September 30, 2018
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Chiba University Hospital Clinical Research Center

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\)\[Criteria for DSP] First episode schizophrenia 2\)\[Criteria for DSP] Unstable and continuous severe psychotic symptoms under antipsychotic treatment for more than 3 months 3\))\[Criteria for DSP] Deficit syndrome 4\)Contraindication to blonanserin/olanzapine

Outcomes

Primary Outcomes

Not specified

Similar Trials